Skip to content

Outcome of modified Misgav Ladach (MML) method in first and second time caesarean deliveries

Outcome of modified Misgav Ladach (MML) method in first and second time caesarean deliveries: a non-randomised controlled single-centre trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN26532492
Enrollment
200
Registered
2009-02-19
Start date
2008-11-15
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caesarean deliveries Pregnancy and Childbirth

Interventions

This trial is taking place at the Istanbul Bakirkoy Maternity and Children's Hospital, Department of Obstetrics and Gynaecology. Approximately 200 patients will be recruited, 50 patients in each of

Sponsors

Istanbul Bakirkoy Maternity and Children's Hospital (Turkey)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Term pregnancies >36 weeks of gestation 2. No age limit

Exclusion criteria

Exclusion criteria: 1. Intrauterine infection 2. Anaemia (37.5 Celsius) 6. Use of antibiotics in the last 7 days 7. Placenta previa 8. Abruptio placenta 9. Severe preeclampsi and Hellp syndrome

Design outcomes

Primary

MeasureTime frame
Surgical outcomes: 1. Operation time 2. Time until delivery of neonate 3. APGAR score 4. Haemoglobin 5. Haematocrit 6. Surgical complications

Secondary

MeasureTime frame
Post-operative outcomes: 1. Hospital stay 2. Febrile morbidity 3. Scar complications 4. Infection 5. Post-operative recovery Secondary outcomes 2 to 5 were assessed 2 and 7 days after caesarean operation. However, patients who experienced any problem were followed-up until resolution of the problem.

Countries

Turkey

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026